Salarius Pharmaceuticals's total assets for Q2 2024 were $3.55M, a decrease of -27.23% from the previous quarter. SLRX total liabilities were $1.18M for the fiscal quarter, a -4.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.